Media 280723

CTO Mr Craig Weller said on Aqua Phase studies revealing the absorption of CBD as more than 4 times greater than CBD in oil:
Bod has been sweating on the PK study for months. It needed to show improved bioavailability of 30% for the deal to proceed, it exceeded by a factor of 10, what this means is that if we ingest 100mg of CBD in oil, we will normally absorb 6-8% of the dose. With Aqua Phase, the CBD absorption is 32% This means we can either get a better response to the CBD or otherwise we can reduce the Aqua Phase dose – giving potentially less side effects and providing CBD raw material savings.
Bod Australia gains approval to commence importing medicinal cannabis oil
23 Feb 2018
Published by: Small Caps
Bod Australia upscales natural medicines range in tandem with growing demand
14 Feb 2018
Published by: Small Caps
Bod Australia signs agreement to develop a line of hemp-based Manuka honey
19 Jan 2018
Published by: Business News Australia
Bod Australia to develop hemp Manuka honey product line
18 Jan 2018
Published by: Food and Beverage Industry News
Bod to develop hemp-based manuka honey for global markets with Manuka Pharma
18 Jan 2018
Published by: Small Caps
Bod partners with iX Biopharma to incorporate medicinal cannabis in WaferiX for trials
04 Jan 2018
Published by: Small Caps